Who are DEXTROMETHORPHAN HYDROBROMIDE's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Mucinex, Dextromethorphan hydrobromide with guaifenesin, Ivy Leaves Cough Liquid, Mucinex®, Guaifenesin Syrup, Guafenesin tablets.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dextromethorphan-hydrobromide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

DEXTROMETHORPHAN HYDROBROMIDE — Competitive Intelligence Brief

DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Expectorant [EPC].

marketed Expectorant [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
DEXTROMETHORPHAN HYDROBROMIDE TARGET	DEXTROMETHORPHAN HYDROBROMIDE		marketed	Expectorant [EPC]		1984-01-01
Mucinex	guaifenesin	Generic (multiple manufacturers)	marketed	Expectorant [EPC]	Vagal gastric reflex → increased respiratory secretions	1952-01-01
Dextromethorphan hydrobromide with guaifenesin	Dextromethorphan hydrobromide with guaifenesin	Washington University School of Medicine	marketed	Antitussive/expectorant combination	Sigma-1 receptor, NMDA receptor (dextromethorphan); non-specific expectorant mechanism (guaifenesin)
Ivy Leaves Cough Liquid	Ivy Leaves Cough Liquid	Engelhard Arzneimittel GmbH & Co.KG	marketed	Herbal expectorant
Mucinex®	Mucinex®	Reckitt Benckiser LLC	marketed	Expectorant
Guaifenesin Syrup	Guaifenesin Syrup	Liaoning University of Traditional Chinese Medicine	marketed	Expectorant
Guafenesin tablets	Guafenesin tablets	American Health Research	marketed	Expectorant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Expectorant [EPC] class)

· 1 drug in this class
Generic (multiple manufacturers) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DEXTROMETHORPHAN HYDROBROMIDE — Competitive Intelligence Brief. https://druglandscape.com/ci/dextromethorphan-hydrobromide. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab